BioCentury
ARTICLE | Regulation

A little less ODAC

August 11, 2003 7:00 AM UTC

When FDA's Oncologic Drugs Advisory Committee last met on March 13, the committee's executive secretary announced that ODAC would not meet in June as planned. Some agency watchers concluded that there would be no major cancer drug approval announcements until fall.

While that would have been a good bet in the past, in this case it meant something else. ...